中医内科学教育部重点实验室全体成员携手奋进，锐意拼搏，论文发表创新历史新高。2020年度共计发表学术论文160篇，其中SCI收录合计70篇，影响因子合计237.78，中科院分区1区4篇，2区25篇，单篇最高影响因子9.986；中文期刊90篇，均为核心期刊。

2021为“十四五”开局之年，全体同仁将以东迁通州院区为契机，砥砺奋进新征程，向着科技创新再出发。不忘初心、牢记使命、传承精华、守正创新、人心向学、和合共进，继续创造更好成绩，续写科技崭新篇章！

抓住机遇，奋勇前进！

英 文 文 章

1.  心血管病方向

[1] Xinyu Yang,Na An,Changming Zhong,Manke Guan,YuchenJiang,Xinye Li,Hanlai Zhang,Liqin Wang,Yanfei Ruan,Yonghong Gao,Nian Liu*,HongcaiShang*,Yanwei Xing*. Enhanced cardiomyocyte reactive oxygen speciessignaling promotes ibrutinib-induced atrial fibrillation[J]. RedoxBiology,2020,30.（SCI收录，IF 9.986）............................................................................................................1

[2]Xinye Li^#,YandaLi^#,Tiansong Zhang,Xingjiang Xiong,Nian Liu,Bing Pang,YanfeiRuan,Yonghong Gao,Hongcai Shang*,Yanwei Xing*. Role ofcardioprotective agents on chemotherapy-induced heart failure: A systematicreview and network meta-analysis of randomized controlled trials[J].Pharmacological Research,2020,151.（SCI收录，IF 5.893）.............................................................................2

[3]Xinyu Yang^#,GuopingLi^#,Tao Yang,Manke Guan,Na An,Fan Yang,Qianqian Dai,ChangmingZhong,Changyong Luo,Yonghong Gao*,Saumya Das*,Yanwei Xing*,HongcaiShang*,Valentina Sala. Possible Susceptibility Genes for Interventionagainst Chemotherapy-Induced Cardiotoxicity[J]. Oxidative Medicine and CellularLongevity,2020,2020.（SCI收录，IF 5.076）................................................3

[4] Fan Yang,Hengwen Chen,Yonghong Gao,NaAn,Xinye Li,Xiandu Pan,Xinyu Yang,Li Tian,Jiahao Sun,Xingjiang Xiong*,YanweiXing*. Gut microbiota-derived short-chain fatty acids and hypertension:Mechanism and treatment[J]. Biomedicine & Pharmacotherapy,2020,130.（SCI收录，IF 4.545）...............................4

[5]Lei Wang ^#, Wuxia Zhang^# ,Ziwen Lu, Baofu Wang , Yang Li , Jingjing Yang , Peng Li* , Mingjing Zhao*.FunctionalGene Module-Based Identification of Phillyrin as an Anticardiac Fibrosis Agent，Front Pharmacol. 2020 Jul 17;11:1077.doi:10.3389/fphar.2020.01077. eCollection 2020（SCI收录，IF 4.225）......5

[6]Wuxia Zhang^# , Lei Wang^#, Ziwen Lu , Baofu Wang , Yang Li , Jingjing Yang , Jinxin Meng , Jinzhong Zhao , Mingjing Zhao* , Peng Li *.Discovery of Natural Compounds for Cardiac Fibrosis by a Transcriptome-BasedFunctional Gene Module Reference Approach.[J]. Journal of naturalproducts,2020,83(10).（SCI收录，IF 3.779）.....................................................................................................6

[7] Wenkun Cheng,Lei Wang,Tao Yang,Aiming Wu,Baofu Wang,TongLi,ZiwenLu,Jingjing Yang,Yang Li,Jiang Yangyang,Wu Xiaoxiao,Meng Hui,MingjingZhao*. Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility inRats With Heart Failure After Myocardial Infarction[J]. Frontiers inPhysiology,2020.（SCI收录，IF 3.376）.................................................................................................7

[8] Yingdong Lu* , Jing Wu *, Yuchan Sun , Laiyun Xin , Zhilin Jiang , Hongchen Lin , Mingjing Zhao , Xiangning Cui.Qiliqiangxinprevents right ventricular remodeling by inhibiting apoptosis and improvingmetabolism reprogramming with pulmonary arterial hypertension.[J]. Americanjournal of translational research,2020,12(9).（SCI收录，IF 3.375）.........................................................................8

[9] Gehui Ni^# , Kai Wang ^#, Yufei Zhou , Xiaodong Wu , Jiaqi Wang , Hongcai Shang* , Lijun Wang *, Xinli Li*.Citri reticulatae Pericarpium attenuates Ang II-induced pathologicalcardiac hypertrophy via upregulating peroxisome proliferator-activatedreceptors gamma.Ann Transl Med. 2020 Sep;8(17):1064.doi:10.21037/atm-20-2118.（SCI收录，IF 3.297）.......................................................................9

[10]Tao Yang^#,ZiwenLu^#,Lei Wang,Yizhou Zhao,Binbin Nie,Qing Xu,Xiaowan Han,Tong Li,JiuliZhao,Wenkun Cheng,Baofu Wang,Aiming Wu,Haiyan Zhu,WeiMeng,Hongcai Shang*,MingjingZhao*. Dynamic Changes in Brain Glucose Metabolism and Neuronal Structurein Rats with Heart Failure.[J]. Neuroscience,2020,424.（SCI收录，IF 3.056）...........................................................................10

[11] Ziwen Lu,Tao Yang,Lei Wang,Qi Qiu,Yizhou Zhao,AimingWu,Tong Li,Wenkun Cheng,Baofu Wang,Yang Li,Jingjing Yang,Mingjing Zhao*.Comparison of different protocols of Morris water maze in cognitive impairmentwith heart failure[J]. Brain and Behavior,2020,10(2).（SCI收录，IF 2.091）...................11

[12] Xiaoyu Zhang^#,Guihua Tian^#,ZhaofengShi^#,Yang Sun,Jiayuan Hu,Yin Jiang,Rui Zheng,Shiqi Chen,ChengyuLi,Xinyu Yang,Tianmai He,Songjie Han,Chi Zhang,Lijing Zhang*,YanLiu*,Hongcai Shang*. Initiate Danhong Injection before or afterpercutaneous coronary intervention for microvascular obstruction inST-elevation myocardial infarction (DIRECTION): study protocol for a randomizedcontrolled trial[J]. Trials,2020,21(1).（SCI收录，IF 1.833）............................12

[13]Yanping Wang,XuZhou,Xiaofan Chen,Fei Wang,Weifeng Zhu,Dongmei Yan*,Hongcai Shang*,ArthurDe Sá Ferreira. Efficacy and Safety of Shengmai Injection for Chronic HeartFailure: A Systematic Review of Randomized Controlled Trials[J]. Evidence-BasedComplementary and Alternative Medicine,2020,2020.（SCI收录，IF 1.813）........................................................................................13

[14] Zhaofeng Shi,Chen Zhao,Jiayuan Hu,Qianqian Dai,MankeGuan,Changming Zhong,Guihua Tian,Hongcai Shang*,Ciara Hughes. TheApplication of Traditional Chinese Medicine Injection on Patients with AcuteCoronary Syndrome during the Perioperative Period of Percutaneous CoronaryIntervention: A Systematic Review and Meta-Analysis of Randomized ControlledTrials[J]. Evidence-Based Complementary and Alternative Medicine,2020.（SCI收录，IF 1.813).........14

[15] Zhaofeng Shi,Chen Zhao,Manke Guan,Xuxu Wei,JiayuanHu,Xiaoyu Zhang,Min Li,Hongcai Shang*,Francesca Mancianti.Individualized Efficiency of Traditional Chinese Medicine for Non-ST SegmentElevation Acute Coronary Syndrome: Study Protocol for Observational Research bythe Evidence-Based Goal Attainment Scale[J]. Evidence-Based Complementary andAlternative Medicine,2020,2020.（SCI收录，IF 1.813）.................................................................................15

[16]Na An ^# , Yu Chen ^# , Yanfen Xing ^# , Honghua Wu ^# , Xiongyi Gao , Hengwen Chen , Ke Song , Yuanyuan Li , Xinye Li, Fan Yang , Xiandu Pan , Xiaofang He , Xin Wang , Yang Li , Yonghong Gao* , Yanwei Xing*, CardiacCaMKII δ and Wenxin Keli Prevents Ang II-Induced CardiomyocyteHypertrophy by Modulating CnA-NFATc4 and Inflammatory Signaling Pathways inH9c2 Cells. Evid Based Complement Alternat Med. 2020 Oct19;2020:9502651.doi: 10.1155/2020/9502651. eCollection 2020.（SCI收录，IF 1.813）................................................16

[17] Cheng-yu Li,Yao-long Chen,Jia-yuan Hu,Min Li,Xiao-yuZhang,Yang Sun,Rui Zheng,Shi-qi Chen,Song-jie Han,Tian-mai He,Hong-caiShang*. Status Quo and Analysis of the Cardiovascular Clinical PracticeGuidelines/Expert Consensuses of Chinese and Integrative Medicine: A SystematicReview[J]. Chinese Journal of Integrative Medicine,2021,27.（SCI收录，IF 1.545）..........................17

[18] Zhendong Feng,Han Xue Jiang,Huiyang Chen,Yu NingLiu,Yahui Wang,Rui Bing Yang,Xueting Han,Chen Hui Xia,Ze Bing Zhu,HongcaiShang,Aiming Wu*,Wei Jing Liu*,Michael S. Wolin. AdaptiveAutophagy Offers Cardiorenal Protection in Rats with Acute MyocardialInfarction[J]. Cardiology Research and Practice,2020,2020.（SCI收录，IF 1.3）.........................................................18

2.脑血管病方向

[19] Ke Song,YuanyuanLi,Hanlai Zhang,Na An,Yufei Wei,Liqin Wang,Chao Tian,Mengchen Yuan,YikunSun,Yanwei Xing*,Yonghong Gao*,Juan Francisco Santiba?ez. OxidativeStress-Mediated Blood-Brain Barrier (BBB) Disruption in NeurologicalDiseases[J]. Oxidative Medicine and Cellular Longevity,2020,2020.（SCI收录，IF5.076）............................................................................................19

[20] Shuai Mao^#, Lei Wang^#,Xujie Zhao^#, Liheng Guo, Qian Lin,Xiaofeng Wang,Xiaohua Dai,Hongcai Shang,Minzhou Zhang*,Hinek Aleksander. Efficacy of SodiumTanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute CoronarySyndrome Undergoing Percutaneous Coronary Intervention: Results from aMulticentre, Controlled, Randomized Trial.[J]. Cardiovascular drugs andtherapy,2020.（SCI收录，IF4.069）.......................................................................20

[21] Yuanyuan Li,KeSong,Hanlai Zhang,Mengchen Yuan,Na An,Yufei Wei,Liqin Wang,Yikun Sun,YanweiXing*,Yonghong Gao*. Anti-inflammatory and immunomodulatory effects ofbaicalin in cerebrovascular and neurological disorders[J]. Brain ResearchBulletin,2020,164.（SCI收录，IF3.37）................................................................................................................................21

[22] Wang Yahan,ChenFang,Wang Pengwen*,Mana Lulu,Sheng Ning,Huang Shuaiyang, Study on myelininjury of AD mice treated with Shenzhiling oral liquid in the PI3K/Akt–mTORpathway[J]. International Journal of Immunopathology and Pharmacology,2020,3（SCI收录，IF2.209）.........................................................22

[23] Liu Zhenhong,QinGaofeng,Mana Lulu,Dong Yunfang,Huang Shuaiyang,Wang Yahan,Wu Yiqiong,ShiJing,Tian Jinzhou,Wang Pengwen*. GAPT regulates cholinergic dysfunctionand oxidative stress in the brains of learning and memory impairment miceinduced by scopolamine.[J]. Brain and behavior,2020,10(5).（SCI收录，IF2.091）...........................................................................................23

[24] DongruiZhou,Liandi Xie,YaoWang,Shuang,Liu Fenzhig Wu,Shuangshuang Zhang,Ruijia Liu,LingqunZhu*. Clinical Efficacy of Tonic Traditional Chinese Medicine Injection onAcute Cerebral Infarction: A Bayesian Network Meta-Analysis[J]. Evidence-BasedComplementary and Alternative Medicine,2020,2020. （SCI收录，IF1.813）...........................................................................................24

[25] FengZhiLiu,Qian,Liu Zhao Suxian,Xu Yingzhi, Dongrui Zhou,Ying Gao*,Lingqun Zhu*.Revealing the Pharmacological Mechanism of Acorus tatarinowii in theTreatment of Ischemic Stroke Based on Network Pharmacology.[J]. Evidence-basedcomplementary and alternative medicine : eCAM,2020,2020. （SCI收录，IF1.813）......................................................................................................25

[26] ShuangWu,Tiantian Yang,Kai Cen,Yihuai Zou,Xiaowei Shi,Dongrui Zhou,Yonghong Gao,LiminChai,Yizhou Zhao,Yikun Sun,Lingqun Zhu*. In Vitro Evaluation of theNeuroprotective Effect of Panax notoginseng Saponins by Activating theEGFR/PI3K/AKT Pathway[J]. Evidence-Based Complementary and AlternativeMedicine,2020,2020.（SCI收录，IF1.813）.........................................26

3. 肾脏病、内分泌、风湿免疫方向

[27] Zheng HJ ^#, Guo J^#, Wang QH^#, Wang LS, Wang YH, Zhang F, HuangWJ, Zhang WT, Liu WJ*, Wang YX*:Probiotics, prebiotics, andsynbiotics for the improvement of metabolic profiles in CKD patients: asystematic review and meta-analysis of randomized controlled trials.Crit RevFood Sci Nutr. 1-22.,2020.（SCI收录，IF7.9）...............................................................................................................27

[28] Zheng Q, Yang H,Liu YN*, and Liu WJ*. In response to "Title: Letter to the Editorin response to the article 'Efficacy and safety of HIF prolyl hydroxylaseinhibitor vs epoetin and darbepoetin for anemia in chronic kidney diseasepatients not undergoing dialysis: A network meta-analysis'". Pharmacol 2021Jan;163:105227.2020.（SCI收录，IF5.9）................................................................................................28

[29] ZhengQ, Yang H, Sun L, Wei RJ, Fu XW, Wang YH, Huang YS, Liu YN*, and Liu WJ*. Efficacyand safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin foranemia in chronic kidney disease patients not undergoing dialysis: A networkmeta-analysis .Pharmacol Res. 159:105020,2020.（SCI收录，IF5.9）............................................................................................................................29

[30] JingGuo,Hui Juan Zheng,Wenting Zhang,Wenjiao Lou,Chenhui Xia,Xue Ting Han,Wei JunHuang,Fan Zhang,Yaoxian Wang*,Wei Jing Liu*,Gianna Ferretti. AcceleratedKidney Aging in Diabetes Mellitus[J]. Oxidative Medicine and CellularLongevity,2020,2020.（SCI收录，IF5.1）............................................30

[31]Wei-junHuang,Wei-jing Liu,Yong-huaXiao,Hui-juan Zheng,Yao Xiao,Qi Jia,Han-xue Jiang,Ze-bing Zhu,Chen-huiXia,Xue-ting Han,Rui-xi Sun,He Nan,Zheng-dong Feng,Shi-dong Wang*,Jin-xi Zhao*.Tripterygium and its extracts for diabetic nephropathy: Efficacy andpharmacological mechanisms[J]. Biomedicine & Pharmacotherapy,2020,121.（SCI收录，IF4.545）..................................31

[32]Zheng QY, Yang HS, Fu XW, Huang YS, Wei RJ, Wang YH,Liu YN*, and Liu WJ*:The efficacy and safety of roxadustat for anemia inpatients with chronic kidney disease: a meta-analysis. Nephrol Dial Transplant.2020. （SCI收录，IF4.5）..........................................................................................................................32

[33]Hui Juan Zheng^#,Xueqin Zhang^#,Jing Guo,WentingZhang,Sinan Ai,Fan Zhang,Yaoxian Wang*,Wei Jing Liu*. Lysosomaldysfunction–induced autophagicstress in diabetic kidney disease[J]. Journal of Cellular and MolecularMedicine,2020,24(15). （SCI收录，IF4.5）..........................................................33

[34] ZeBing Zhu,Ke Song,Wei Jun Huang,Hui Li,Hui Yang,Yun Qi Bai, Ke Ting Guo,Rui BingYang,Wen Jiao Lou,Chen Hui Xia,Bo Nie*,Wei Jing Liu*. Si-Miao-Yong-An(SMYA) Decoction May Protect the Renal Function Through Regulating theAutophagy-Mediated Degradation of Ubiquitinated Protein in an AtherosclerosisModel[J]. Frontiers in Pharmacology,2020.（SCI收录，IF4.2）

......................................................................................................................................34

[35]ZhenyingZuo,Kaipeng Jing,Hongluan Wu,Shujun Wang,Lin Ye,Zhihang Li,Chen Yang,QingjunPan,Wei Jing Liu*,HuaFeng Liu*. Mechanisms and Functions ofMitophagy and Potential Roles in Renal Disease.[J]. Frontiers inphysiology,2020,11.（SCI收录，IF3.4）............................................................................35

[36]Yi Shan Huang,Qiyan Zheng,Huisheng Yang,Xinwen Fu,Xueqin Zhang, Chenhui Xia,Zebing Zhu ,Yu Ning Liu*,Wei Jing Liu *.Efficacy of Intermittent or Continuous Very Low-Energy Diets in Overweight andObese Individuals with Type 2 Diabetes Mellitus: A Systematic Review andMeta-Analyses.[J]. Journal of diabetes research,2020,2020.（SCI收录，IF3.0）................................................................36

[37]Jiang Chen^#,Fan Zhang^#,Chu-YinLiu,Qiao-Mei Yuan,Xue-Shi Di,Shui-Wen Long,Hong-Cai Shang*,Yu-Song Jia*.Impact of chronic kidney disease on outcomes after total joint arthroplasty: ameta-analysis and systematic review[J]. International Orthopaedics,2020,44(12).（SCI收录，IF2.854）................................................37

[38]Liu J, Wei J, Wang C, Meng X, Chen H, Deng P, HuandikeM, Zhang H, Li X, Chai L*. The combination of Radix Astragali and RadixAngelicae Sinensis attenuates the IFN-γ-induced immunedestruction of hematopoiesis in bone marrow cells. BMC Complement Altern Med.2019 Dec 9;19(1):356.（SCI收录，IF2.833）......................................................................................................................38    

[39] Jinyu Li,XiaoyingMeng,Changzhi Wang,Huijie Zhang,Hening Chen, Peiying Deng,Juan Liu,Meiyier Huandike,JieWei*,Limin Chai*. Coptidis alkaloids extracted from Coptischinensis Franch attenuate IFN-γ-induced destruction of bone marrow cells.[J].PloS one,2020,15(7).（SCI收录，IF2.74）..............................................................................................................................39

[40]Han Xue Jiang ^#,Zhendong Feng^#,ZeBing Zhu ,Chen Hui Xia, Wenting Zhang,Jing Guo,Bao-Li Liu,Yaoxian Wang,Yu NingLiu*,Wei Jing Liu*. Advances of the experimental models ofidiopathic membranous nephropathy (Review).[J]. Molecular medicinereports,2020,21(5).（SCI收录，IF2.1）................................40

[41] Chen H, Wang C, Li J, Huandike M, LiuJ, Huang Q, Li X, Zhang H, Zhou J*, Chai L*. Chinese Herbal Formula,Huayu Tongbi Fang, Attenuates Inflammatory Proliferation of Rat SynoviocytesInduced by IL-1 by RegulatingProliferation and Differentiation of TLymphocytes. Evid Based Complement Alternat Med. 2020 May 19;2020:1706837（SCI收录，IF1.813）.................................................................41

[42]YSHuang^#, X Wang^#, ZD Feng, HL Cui, ZB Zhu, CH Xia, XT Han,YN Liu*, WJ Liu*:Cordyceps cicadae Prevents Renal TubularEpithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in HypertensiveRenal Injury. Evid Based Complement Alternat Med. 2020:7202519,2020. （SCI收录，IF1.8）................42

[43]Yong-Xin Ru*, Hong-Cai Shang, Shu-Xu Dong,Shi-Xuan Zhao, Hao-Yue Liang,Chao-Jun Zhu. Foam cell origination fromdegenerated vascular smooth muscle cells in atherosclerosis: An ultrastructuralstudy on hyperlipidemic rabbits[J]. Ultrastructural Pathology,2020,44(1).（SCI收录，IF0.989）................................43

4. 循证评价方向

[44] Y Li, J Ma*, YJin, N Li, R Zheng, W Mu, J Wang, JH Si, J Chen, HC Shang. Benzodiazepinesfor treatment of patients with delirium excluding those who are cared for in anintensive care unit.[J]. The Cochrane database of systematic reviews,2020,2.（SCI收录，IF7.89）.....................................................................44

[45]Jianfeng Xie,Hongliang Wang,Yan Kang,LixinZhou,Zhongmin Liu,Bingyu Qin,Xiaochun Ma,Xiangyuan Cao,Dechang Chen,WeihuaLu,Chen Yao,Kaijiang Yu,Xiaoqing Yao,Hongcai Shang,Haibo Qiu,Yi Yang.The Epidemiology of Sepsis in Chinese ICUs: A National Cross-SectionalSurvey[J]. Critical Care Medicine,2019.（SCI收录，IF7.414）.............................................................................................45

[46] Xinye Li^#,Xiandu Pan^#,YandaLi^#,Na An^#,Yanfen Xing,Fan Yang,Li Tian,Jiahao Sun,YonghongGao,Hongcai Shang*,Yanwei Xing*. Cardiac injury associated withsevere disease or ICU admission and death in hospitalized patients withCOVID-19: a meta-analysis and systematic review[J]. Critical Care,2020,24(1)（SCI收录，IF6.407）......................................................................................46

[47]Xue Xu^#,Kuo Yang^#,Feilong Zhang^#,WenwenLiu,Yinyan Wang,Changying Yu,Junyao Wang,Keke Zhang,Chao Zhang,GoranNenadic,Dacheng Tao,Xuezhong Zhou*,Hongcai Shang*,Jianxin* Chen. Identificationof herbal categories active in pain disorder subtypes by machine learning helpreveal novel molecular mechanisms of algesia[J]. PharmacologicalResearch,2020,156.（SCI收录，IF5.893）...........47

[48]Runsheng Xie,Yun Xia,Yaolong Chen*,Hui Li*,Hongcai Shang,XinyingKuang,Linjun Xia,Yi Guo. The RIGHT Extension Statement for Traditional ChineseMedicine: Development, Recommendations, and Explanation[J]. PharmacologicalResearch,2020,160.（SCI收录，IF5.893）.............................................................48

[49] RuijinQiu,Chen Zhao,Tengxiao Liang,Xuezeng Hao,Ya Huang,Xiaoyu Zhang,Zhao Chen,XuxuWei,Mengzhu Zhao,Changming Zhong,Jiayuan Hu,Min Li, Songjie Han,Tianmai He,YangSun,Jing Chen,Hongcai Shang*. Core Outcome Set for Clinical Trials ofCOVID-19 Based on Traditional Chinese and Western Medicine.[J]. Frontiers inpharmacology,2020,11.（SCI收录，IF4.225）.......49

[50] Zhang J, Sun Y,Zhou K, Zhang X, Chen Y, Hu J, Zhong C, Liu Y*, Shang H*. Rationale anddesign of the AUGUST-AHF Study [published online ahead of print, 2020 Jun 22].ESC Heart Fail. 2020;10.1002/ehf2.12787. doi:10.1002/ehf2.12787（SCI收录，IF3.902）............................................................................................50

[51] Ye Yong-An*and TheG-CHAMPS Collaborative Group.Guideline-Based Chinese Herbal Medicine TreatmentPlus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): EvidenceFrom China.[J]. Frontiers in medicine,2020,7.（SCI收录，IF3. 9）...............................................................................................51

[52] Yuanjie Sun^#,YanLiu^#,Tongsheng Su,Jianhua Sun,Ying Wu,Zhishun Liu*.Electroacupuncture versus solifenacin for women with urgency-predominant mixedurinary incontinence: a protocol for a three-armed non-inferiority randomizedcontrolled trial.[J]. BMC complementary medicine and therapies,2020,20(1)（SCI收录，IF3.414）..................................................................................................52

[53] RuiZheng,Liyuan Tao,Kwong Joey S W,Changming Zhong,Chengyu Li,Shiqi Chen,YangSun,Xiaoyu Zhang,Hongcai Shang*. Risk factors associated with theseverity of adverse drug reactions by Xiyanping injection: A propensityscore-matched analysis.[J]. Journal of ethnopharmacology,2020,250.（SCI收录，IF 3.209）.......................................................................................................................53

[54] Zhitao Hou,RuijinQiu,Qingshuang Wei,Yitian Liu,Meng Wang, Tingting Mei,Yue Zhang,LiyingSong,Xianming Shao,Hongcai Shang*,Jing Chen*,Sun Zhongren*.Electroacupuncture Improves Cognitive Function in Senescence-Accelerated P8(SAMP8) Mice via the NLRP3/Caspase-1 Pathway.[J]. Neural plasticity,2020,2020.（SCI收录，IF3.093）...........................................................54

[55] X Zhang, L Lan, JCPChan, LLD Zhong,CW Cheng, WC Lam, R Tian, C Zhao, TX Wu, HC Shang, LyuAP, Bian ZX*. WHO Trial Registration Data Set (TRDS) extension for traditionalChinese medicine 2020: recommendations, explanation, and elaboration. BMC MedRes Methodol. 2020;20(1):192.

（SCI收录，IF3.031）...........................................................................................55

[56]Yan Liu,ChiZhang,Chengyu Li,Chunxue Bai,Hongcai Shang*. Marked Reduction in 28-dayMortality Among Elderly Patients with Severe Community-acquired Pneumonia: PostHoc Analysis of a Large Randomized Controlled Trial.[J]. Clinical interventionsin aging,2020,15.（SCI收录，IF3.023）.........................................................................................................................56

[57] XuanZhang,Ran Tian,Wai Ching Lam,Yuting Duan,Fan Liu,Chen Zhao,Taixiang Wu,HongcaiShang,Xudong Tang,Aiping Lyu,Zhaoxiang Bian*. Standards for reportinginterventions in clinical trials of cupping (STRICTOC): extending the CONSORTstatement[J]. Chinese Medicine,2020,15(1).（SCI收录，IF2.96）................................................................................................................................57

[58] Biyun Sun,YanLiu,Tongsheng Su,Yuanjie Sun,Zhishun Liu*. Electroacupuncture forstress-related urinary incontinence in elderly women: data analysis from tworandomised controlled studies.[J]. BMJ supportive & palliative care,2020.（SCI收录，IF2.681）.........................................................................................58

[59] WeimingWang ^# , SixingLiu ^# , Yan Liu ^# , ZhiweiZang , WeinaZhang , Liang Li , ZhishunLiu*. Efficacy of acupuncture versus sham acupuncture orwaitlist control for patients with chronic plantar fasciitis: study protocolfor a two-centre randomised controlled trial.BMJ Open. 2020 Sep25;10(9):e036773. doi: 10.1136/bmjopen-2020-036773（SCI收录，IF2.496）..........................................59

[60]Chao Tian^#,Na An^#,Mengchen Yuan^#,LiqinWang,Hanlai Zhang,Xinye Li, Xinyu Yang,Yanda Li,Kengo F Kusano,Yonghong Gao*,YanweiXing*. A Pooled Analysis of the Prognostic Significance of Brugada Syndromewith Atrial Fibrillation.[J]. Current pharmaceutical design,2020,26（SCI收录，IF2.208）.............................60

[61] Weiming Wang^#,YanLiu^#,Ruimin Jiao^#,Sixing Liu,Jie Zhao,Zhishun Liu*.Comparison of electroacupuncture and manual acupuncture for patients withplantar heel pain syndrome: a randomized controlled trial.[J]. Acupuncture inmedicine : journal of the British Medical Acupuncture Society,2020（SCI收录，IF2.129）.........................................................................................................................61

[62] JingFu,Hong-Cai Shang,Li-Ying Wang,Chen Zhao,Xiao-Fang Yang,Wei-WeiGuo,Chun-Xia Lu,Jin Cui*,Yan-Ping Wang*. Clinical efficacy evaluation of atraditional Miao technique of crossbow needle therapy in the treatment of kneeosteoarthritis: a multi-center randomized controlled trial[J]. Trials,2020,21(6).（SCI收录，IF1.883）..........................................................................................62

[63] ShiyaHuang^#,Min Hu^#,Ernest Hung Yu Ng^#,ElisabetStener-Victorin,Yanhua Zheng,Qidan Wen,Cong Wang,Maohua Lai,Juan Li,XingchengGao,Xinhua Wang,Zhenxing Hu,Tian Xia,Rongkui Hu,Jianping Liu,Xiaohui Wen,ShunaLi,Kewei Quan,Xingyan Liang,Hongcai Shang,Hongxia Ma*,Jie Qiao*. Amulticenter randomized trial of personalized acupuncture, fixed acupuncture,letrozole, and placebo letrozole on live birth in infertile women withpolycystic ovary syndrome[J]. Trials,2020,21(3).（SCI收录，IF1.883)........................................................63

[64] Zhenhong Liu,Gaofeng Qin,Mana Lulu,Shuaiyang Huang,Yahan Wang,Pengwen Wang*.ShenzhilingOral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTORPathway.[J]. Evidence-based complementary and alternative medicine :eCAM,2020,2020.（SCI收录，IF1.813）.........................................................................................................................64

[65] JinyuLi,Wei Wang,Guiyu Feng,Jian Du,Shengqian Kang,Zhe Li,Weifeng Zhu*,HongcaiShang*,Olumayokun A. Olajide. Efficacy and Safety of Duhuo JishengDecoction for Postmenopausal Osteoporosis: A Systematic Review andMeta-Analysis[J]. Evidence-Based Complementary and AlternativeMedicine,2020,2020.（SCI收录，IF1.813）......................................................................................65

[66] BinYanYu,YanPing Wang,HongCaiShang,LiYing Wang,YiJia Wan,ChenZhao,LiHua Xuan*. Effect of Thick-Needle Therapy in Patients with Bell'sPalsy at Recovery Stage: A Multi-center Randomized Controlled Trial.[J].Chinese journal of integrative medicine,2020,26(6).（SCI收录，IF1.545）...................66

5. 中药药理及作用机制方向

[67] YuSang Li*,JianZhang*,GuiHua Tian*,Hong CaiShang*,Tang He Bin*. Kirenol, darutoside andhesperidin contribute to the anti-inflammatory and analgesic activities ofSiegesbeckia pubescens makino by inhibiting COX-2 expression and inflammatorycell infiltration[J]. Journal of Ethnopharmacology,2020（SCI收录，IF3.69）......................................................................................................................67

[68] Chengyu Li^#,PingWang^#,Min Li,Rui Zheng,Shiqi Chen,Si Liu,Zhiqiao Feng,Yongming Yao,HongcaiShang*. The current evidence for the treatment of sepsis with Xuebijinginjection: Bioactive constituents, findings of clinical studies and potentialmechanisms[J]. Journal of Ethnopharmacology,2021,265.（SCI收录，IF3.69）...........................................................................................................................68

[69]Pei Lin^#,Qi Wang^#,YueheLiu,Zifei Qin*,Hao Gao,Min Ye,Hongcai Shang,Xinsheng Yao,Zhihong Yao*.Characterization of chemical profile and quantification of representativecomponents of DanLou tablet, a traditional Chinese medicine prescription, byUHPLC-Q/TOF-MS combined with UHPLC-TQ-MS[J]. Journal of Pharmaceutical andBiomedical Analysis,2020,180.

（SCI收录，IF3.209）............................................................................................69

[70] YiShan Huang,Xu Wang,Zhendong Feng,Hailan Cui,Zebing Zhu,Chenhui Xia,Xueting Han,WeiJing Liu,Yu Ning Liu,José L. Rios. Cordyceps cicadae Prevents Renal TubularEpithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in HypertensiveRenal Injury[J]. Evidence-Based Complementary and AlternativeMedicine,2020,2020.（SCI收录，IF1.8）.............................................70

备注：#：共同第一作者；*：通讯作者

中 文 文 章

1. 心血管病方向

[1] 赵希曦,杨洁红,曹雪滨,潘远江,万海同^*,商洪才,张海峰.论心血瘀阻是冠心病慢性心力衰竭的基本病机与证型[J].中华中医药杂志,2020,35(02):827-830...............................................................................................................................71

[2] 刘珂珂,吕梦,纪晓迪,娄利霞,赵一舟,吴爱明^*.稳心颗粒调控内质网应激途径抑制心梗大鼠心肌凋亡的研究[J/OL].中国实验方剂学杂志:1-8[2020-12-31].https://doi.org/10.13422/j.cnki.syfjx.20210337................................72

[3] 张婷,王婕,吴爱明,马喆,赵一舟,张冬梅,金秋硕,娄利霞^*.益气活血方治疗心力衰竭的内质网应激机制研究[J].中国医药导报,2020,17(13):32-36+40...........................................................................................................................73

[4] 徐冰,聂波^*.八味沉香散对缺血再灌注损伤心肌细胞活性氧及钙离子水平影响的研究[J/OL].辽宁中医杂志:1-8[2020-12-31].20201211.1755.046.html...............................................................................74

[5] 白云绮,李慧,宋珂,王淑琪,高照,孙克寒,金秋硕,娄利霞,吴爱明,吴圣贤,聂波^*.ApoE~(-/-)小鼠动脉粥样硬化模型的中医证型初探[J/OL].世界中医药:1-8[2020-12-31].20201102.1200.014.html.................................................75

[6] 张晶晶,刘岩^*,张晓雨,陈莹,商洪才^*.急性心力衰竭临床试验中呼吸困难的测量方法[J].中国循证医学杂志,2020,20(11):1334-1339............................................................................................................................76

[7] 石兆峰,关曼柯,魏旭煦,蒋寅,胡嘉元,张晓雨,赵晨,商洪才^*.中成药治疗非ST段抬高型急性冠脉综合征的网状Meta分析[J/OL].世界中医药:1-17[2020-12-31].20201102.1557.018.html..........................................................................77

[8] 侯志涛,宋晓晨,宋丽颖,李瑒,陈晶,商洪才.基于网络药理学探讨强心胶囊治疗慢性心力衰竭的作用机制[J/OL].世界中医药:1-14[2020-12-31].20201026.1439.010.html.................................................................................78

[9] 李慧敏,熊兴江,赵晖,胡瑞学,商洪才,杨伟,廖星^*.近3年中医药治疗稳定型心绞痛随机对照试验结局指标的现状分析[J].北京中医药大学学报,2020,43(07):606-616........................................................................................79

[10] 李慧敏,熊兴江,胡瑞学,于丹丹,杨伟,廖星^*,商洪才^*.中医药治疗不稳定性心绞痛随机对照试验结局指标的现状分析[J].中国循证医学杂志,2020,20(07):817-828........................................................................................80

[11] 代倩倩,石兆峰,胡嘉元,韩松洁,钟长鸣,关曼柯,田贵华,商洪才.芪参益气滴丸联合西药治疗对经皮冠状动脉介入术后不良心血管事件及生活质量影响的Meta分析[J/OL].中国中药杂志:1-15[2020-12-31].https://doi.org/10.19540/j.cnki.cjcmm.20200618.501.........................81

[12] 黄涯,刘珂珂,吕梦,娄利霞,程涓,聂波,张冬梅,吴爱明^*,赵明镜,商洪才.内质网应激凋亡途径对H9C2细胞缝隙连接蛋白43表达的影响及稳心颗粒的干预研究[J].中国现代中药,2020,22(10):1618-1623...........................................................................................................................82

[13] 王曼曼,国倩倩,吴丹丹,高毅洁,张冬梅^*.冠状动脉临界病变的中西医诊疗新进展[J].中西医结合心脑血管病杂志,2020,18(21):3581-3584....................83

[14] 国倩倩,吴丹丹,高毅洁,王曼曼,朱珂,贾冬冬,杨睿,王京,刘丽,张冬梅^*.扶正化瘀胶囊调节特异性蛋白1相关通路抗心肌纤维化作用机制研究[J].世界中医药,2020,15(12):1714-1718............................................................................84

[15] 吴丹丹,国倩倩,高毅洁,王曼曼,贾冬冬,杨睿,张冬梅^*,朱珂.基于网络药理学探讨活血益气方促进心肌梗死后血管新生作用机制[J].中国中医药信息杂志,2020,27(12):76-82............................................................................................85

[16]李洋,赵明镜^*,王保福,韩小婉,孟慧.细胞外囊泡与心血管疾病[J/OL].中西医结合心脑血管病杂志:1-7[2020-12-31].20201215.1035.002.html..............86

[17]李洋,赵明镜^*,王保福,刘颖,金秋硕,韩小婉,李彤,孟慧.不同来源白细胞微粒诱导巨噬细胞极化的比较研究[J].中西医结合心脑血管病杂志,2020,18(22):3763-3770.....................................................................................87

[18]刘珂珂,黄涯,吕梦,娄利霞,程涓,聂波,张冬梅,吴爱明^*,赵明镜.内质网应激在心血管疾病中的研究进展[J].中西医结合心脑血管病杂志,2020,18(22):3792-3796.....................................................................................88

[19]王达洋,徐筱青,赵明镜,王显^*.基于病理形态学系统综述探讨猪冠状动脉球囊损伤病变与动脉粥样硬化的差异[J].中国实验动物学报,2020,28(05):632-637...............................................................................................................................89

[20]黄涯,刘珂珂,吕梦,娄利霞,程涓,聂波,张冬梅,吴爱明^*,赵明镜,商洪才.内质网应激凋亡途径对H9C2细胞缝隙连接蛋白43表达的影响及稳心颗粒的干预研究[J].中国现代中药,2020,22(10):1618-1623.................................................90

2. 脑血管病方向

[21]黄帅阳,吴艺琼,巩卓彦,王亚晗,玛娜璐璐,刘珍洪,秦高凤,王蓬文^*.金思维对拟散发性AD小鼠海马PSD95和Shank1表达及学习记忆的影响[J].环球中医药,2020,13(05):772-777........................................................................................91

[22]方琼杰,王俊宏^*,丁一芸,任昕昕,周义山,王蓬文.静宁颗粒对注意力缺陷多动障碍模型大鼠认知功能及纹状体单胺类的影响[J].世界中西医结合杂志,2020,15(02):273-277........................................................................................92

[23] 李媛媛,刘珂依,宋珂,刘浩琦,安娜,王丽琴,张涵莱,孙逸坤,朱陵群,邢雁伟,高颖,高永红^*.基于网络药理学和分子对接探讨漏芦防治缺血性脑卒中的作用机制[J].中西医结合心脑血管病杂志,2020,18(22):3735-3744.....................93

[24] 刘蕊嘉,于旭东,徐薇薇,阎明源,王海若,朱陵群^*.从阳虚辨证治失眠[J/OL].海南医学院学报:1-7[2020-12-31].20200608.001................................94

[25] 徐薇薇,吴爽,周冬蕊,陈丹丹,刘蕊嘉,朱陵群^*.交泰丸加减联合乌灵胶囊治疗失眠伴焦虑状态的临床研究[J].中西医结合心脑血管病杂志,2020,18(06):890-893........................................................................................95

[26] 徐薇薇,刘蕊嘉,陈丹丹,吴爽,朱陵群^*.朱陵群治疗顽固性失眠临床经验[J].中西医结合心脑血管病杂志,2020,18(03):540-542....................................96

[27] 刘蕊嘉,张海艳,吴爽,周冬蕊,陈丹丹,徐薇薇,朱陵群^*.从肝论治失眠伴焦虑、抑郁情绪验案举隅[J].环球中医药,2020,13(01):89-92.............................97

3. 循证评价方向

[28] 石兆峰,赵晨^*,胡嘉元,蒋寅,张晓雨,孙杨,商洪才^*.构建中医个体化长时程疗效评价方法[J].中国循证医学杂志,2020,20(12):1373-1378.....................98

[29] 陈耀龙^*,史乾灵,赵俊强,徐东,李慧,邵瑞太,陈彤,刘恩梅,马艳芳,周奇,商洪才,杨克虎.从知到行:跨越指南理论与实践的鸿沟[J].协和医学杂志,2020,11(06):746-753........................................................................................99

[30] 张林子,吴立群,陈睿哲,易玮,周武,谷林,商洪才,张洪来^*.基于数据挖掘的针刺治疗神经根型颈椎病选穴规律分析[J].中国针灸,2020,40(11):1259-1262...........................................................................................................................100

[31] 关曼柯,魏旭煦,赵晨^*,商洪才^*.循证决策模式下中医临床个体化疗效评价研究的定位与未来发展路径[J].中国循证医学杂志,2020,20(10):1124-1129..........................................................................................................................101

[32] 陈耀龙^*,刘萧,王燕平,张誉清,温成平,何东仪,费宇彤,谢雁鸣,史楠楠,李博,李慧,陈昊,杨书,马艳芳,商洪才,杨克虎.西医指南与中医药指南:在相互学习中共同提高[J].协和医学杂志,2020,11(05):615-620..................................102

[33] 侯志涛,宋晓晨,李瑒,陈晶,商洪才.基于网络药理学探讨孔圣枕中丹治疗轻度认知功能障碍的作用机制[J/OL].辽宁中医药大学学报:1-20[2020-12-31].20200927.1654.094.html.............................................................................103

[34] 牟玮,黄宇虹,李艳芬,徐强,王璨,王保和,商洪才^*.基于叙事医学、循证医学的中西医临床共同决策模式构建初探[J].中医杂志,2020,61(18):1598-1603.

...................................................................................................................................104[35] 张晓雨,刘硕,孙杨,邱瑞瑾,陈昭,唐健元^*,商洪才^*.从“三药三方”谈中药新药审评理念、研发思路及策略[J].中国新药杂志,2020,29(16):1818-1821...........................................................................................................................105

[36] 邱瑞瑾,商洪才^*.中医临床研究核心结局指标中的叙事元素[J].中医杂志,2020,61(17):1512-1515..................................................................................106

[37] 邱瑞瑾,赵晨,钟长鸣,胡嘉元,李敏,黄涯,韩松洁,何天麦,关曼柯,陈静,商洪才^*.中医临床疗效个体化评价应用混合方法研究设计思路[J].中国循证医学杂志,2020,20(08):973-978..................................................................................107

[38] 陈江,贾育松,张立晶,邱瑞瑾,袁巧妹,邸学士,龙水文,商洪才^*.骨科围术期心血管风险评估及中医药治疗进展[J].医学研究杂志,2020,49(08):5-8................................................................................................................................108[39] 陈耀龙^*,荀杨芹,李博,王小琴,刘恩梅,徐东,李艳,商洪才,杨克虎.如何制订患者指南[J].协和医学杂志,2020,11(04):453-458......................................109

[40] 陈耀龙^*,张静怡,张天嵩,孙凤,倪小佳,杨楠,王琪,王健健,马艳芳,商洪才,杨克虎.指南的系统评价:是什么,为什么,怎么做[J].协和医学杂志,2020,11(03):320-324.....................................................................................110

[41] 陈耀龙^*,王玲,杨楠,李舍予,王琪,黎国威,宋扬,苏珊,商洪才,杨克虎.临床实践指南如何“保鲜”[J].协和医学杂志,2020,11(02):207-212...........................................................................................................................111

[42] 邱瑞瑾,钟长鸣,关曼柯,胡嘉元,赵晨,陈昭,李敏,韩松洁,何天麦,黄涯,陈静^*,商洪才^*.中西药联用临床安全性评价应引入核心指标集[J].中国循证医学杂志,2020,20(05):511-514..................................................................................112

[43] 张晶晶,刘岩,陈莹,张晓雨,张学成,代恒恒,蒋寅,商洪才^*.新型冠状病毒肺炎临床试验病例报告表及其使用说明[J].医学新知,2020,30(02):116-123..............................................................................................................................113[44] 胡嘉元,邱瑞瑾,李心怡,商洪才,田贵华^*.中医药治疗慢性疼痛临床效应多维评价方法的研究思路[J].世界科学技术-中医药现代化,2020,22(01):1-6.

...................................................................................................................................114[45] 代倩倩,商洪才,李心怡,赵晨,石兆峰,李幼平,田贵华^*.医患共建平行病历在慢性疼痛管理中的应用[J].世界科学技术-中医药现代化,2020,22(01):18-22..............................................................................................................................115

[46] 李承羽,赵晨,陈耀龙,胡嘉元,王燕平,商洪才^*.中医药临床指南/共识中推荐意见分级标准的制订[J].中医杂志,2020,61(06):486-492........................................116

[47] 王燕平,郑蕊,胡嘉元,商洪才.新冠肺炎的中西结合诊疗优势对比[J].家庭中医药,2020,27(03):26-29...................................................................................117

[48] 蒋寅,赵晨,张晓雨,商洪才.人工智能时代的中医临床研究问题与对策[J/OL].中国中西医结合杂志:1-4[2020-12-31].http://kns.cnki.net/kcms/detail/11.2787.R.20200302.1000.013.html.

...................................................................................................................................118

[49] 石兆峰,代倩倩,钟长鸣,张晓雨,赵晨,商洪才^*.基于Nvivo软件的中医药防控新型冠状病毒肺炎质性研究[J].暨南大学学报(自然科学与医学版),2020,41(02):163-174....................................................................................119

[50] 张晓雨,赵晨,孙杨,魏旭煦,关曼柯,赵梦竹,林繄依,商洪才^*.推动建立临床试验协作与共享机制——疫情蔓延期的战略思考[J].中医杂志,2020,61(08):650-654......................................................................................120

[51] 李承羽,张晓雨,刘斯,商洪才^*.血必净注射液治疗新型冠状病毒感染的肺炎(COVID-19)证据基础及研究前瞻[J].世界科学技术-中医药现代化,2020,22(02):242-247.......................................................................................121

4. 中药药理及作用机制方向

[52] 张沂,穆杰,高伟华,金译涵,张迪,贾海女,张亚楠,李金桐,柴立民,晏军^*.基于网络药理学从系统层面探讨黄芩苷治疗肺纤维化的效应机制研究[J].世界中医药,2020,15(10):1373-1380............................................................................122

[53] 陈贺宁,王长志,孟晓莹,美依尔·欢地克,张慧杰,李雪,柴立民^*.基于NF-κB和JAK/STAT通路探讨黄芪、当归、忍冬藤水提冻干粉调控大鼠滑膜细胞增殖和凋亡的作用机制[J].现代中西医结合杂志,2020,29(01):20-24................123

[54] 王淑琪,李慧,杨晓强,白云绮,林繄依,高照,孙克寒,聂波^*.建立大鼠动脉粥样硬化模型的研究进展[J].中国医药导报,2020,17(12):45-48+68............124

[55] 卞兆祥^*,郑颂华,赵晨,张轩,黄韬,林成源,商洪才,钟丽丹.基于麻子仁丸治疗功能性便秘复方研究的整合医学模式探讨[J].中医杂志,2020,61(22):1967-1970...................................................................................125

[56] 代倩倩,李心怡,夏桂阳,夏欢,卫晓红,商洪才,林生^*,田贵华^*.慢性疼痛动物模型研究进展及在中医药研究中的应用[J].中国中药杂志,2020,45(24):5866-5876...................................................................................126

[57] 李心怡,陈荷清,夏欢,林生,商洪才,田贵华^*.蜂胶降脂方对高脂血症模型斑马鱼的降血脂作用研究[J].世界科学技术-中医药现代化,2020,22(05):1629-1635...........................................................................................................................127[58] 代倩倩,夏欢,夏桂阳,商洪才,石兆峰,黄雨丝,李心怡,林生^*,田贵华^*.白芍方药以及白芍总苷镇痛功效及其机理研究进展[J].世界科学技术-中医药现代化,2020,22(01):39-46...........................................................................................128

5. 药物分析方向

[59] 夏桂阳,肖标兵,王玲燕,方冬杰,夏欢,林生^*.醋制延胡索中一个新苄基异喹啉二聚体生物碱[J/OL].药学学报:1-8[2020-12-31].20201125.1641.018.html................................................................................129

[60] 王玲燕^#,夏欢^#,夏桂阳,卫晓红,田贵华^*,林生^*.天然非生物碱类镇痛成分的研究进展[J].中国中药杂志,2020,45(24):5840-5865.......................................130

[61] 王玲燕^#,夏桂阳^#,夏欢,王亚男,卫晓红,田贵华^*,林生^*.天然生物碱类镇痛成分的研究进展[J].中国中药杂志,2020,45(24):5829-5839...........................131

[62] 夏欢,王玲燕,夏桂阳,卫晓红,王亚男,林生^*.山鸡椒乙酸乙酯部位化学成分研究[J].中国中药杂志,2020,45(24):5877-5883...........................................132

[63] 钟万超,李瑞,夏欢,夏桂阳,张景芳,田贵华^#,林生^*.赤芍中的1个新木脂素苷类化合物[J].中国中药杂志,2020,45(12):2903-2906...................................133

[64] 李慧,杨会,白云绮,王淑琪,孙克寒,高照,娄利霞,吴爱明,吴圣贤,聂波^*.基于PPAR-γ激动剂的四妙勇安汤活性部位筛选及其化学成分分析[J].中国医药导报,2020,17(16):28-33.................................................................................134

[65] 郑蕊,关曼柯,钟长鸣,陈诗琪,李承羽,孙杨,商洪才^*.中药注射剂说明书安全性信息报告调查分析[J].中药新药与临床药理,2020,31(03):363-367......135

6. 中医理论方法

[66] 黄为钧,赵进喜^*,王世东,肖永华,傅强,宫晴,张华,李哲.消渴病火热病机新论[J].中医杂志,2020,61(13):1194-1196..........................................................136

[67] 符馨文,李爽,刘伟敬,刘玉宁^#,谢院生^*.Fabry病的中医症状特点与证型分布[J/OL].中国中西医结合杂志:1-7[2020-12-31]. 20200916.1622.014.html.

..................................................................................................................................137

[68] 许宗颖,张迪,陈萌^*,张冬梅.基于四味合法和经方血缘论乌梅丸组方与主治特点[J].中华中医药杂志,2020,35(10):4945-4947..........................................................................................................................138

[69] 周易,陈萌^*,张冬梅,张迪.麻黄汤证“营阴郁滞”病机溯源与辨析[J].中国中医基础医学杂志,2020,26(08):1062-1064..................................................139

7. 肾脏病、内分泌、风湿免疫方向

[70] 刘蔚翔,巩勋,姜泉^*,李克嵩,李延婷,翟争,刘岩.类风湿关节炎湿热与寒湿证候病情指标差异探讨[J].中华中医药杂志,2020,35(05):2515-2518...........140

[71] 南赫,黄晓强,王宣权,黄为钧,赵进喜^*.糖尿病肾病“肾络伏风”病机学说及“从风论治”治法的探讨[J].环球中医药,2020,13(04):620-623...............141

[72] 卢聪,赵进喜^*,黄为钧,张秀媛.同型半胱氨酸与2型糖尿病中医证候关系研究[J].中国医药导报,2020,17(10):118-121.......................................................142

[73] 肖遥,吴双,黄为钧,孙瑞茜,蒋里,张耀夫,赵进喜,傅强^*.2型糖尿病患者的肠道菌群与阳明、太阴体质相关性分析[J].环球中医药,2020,13(03):371-377............................................................................................................................143

[74] 黄为钧,赵进喜^*,王世东,肖永华,傅强,宫晴,张华.再论糖尿病肾脏病“从风论治”[J].中华中医药杂志,2020,35(02):588-590......................................144

[75] 谌贻璞,陈洪宇,刘宝利,周静威,方敬爱^*,刘伟敬^*,刘玉宁^*.肾性水肿的中西医结合诊断与治疗[J].中国中西医结合肾病杂志,2020,21(09):843-846...........................................................................................................................145

[76] 占永立,魏连波,李平,余仁欢,方敬爱^*,刘伟敬^*,刘玉宁^*.慢性肾衰竭浊毒证的中医治疗[J].中国中西医结合肾病杂志,2020,21(07):656-658..............146

[77] 姜韩雪,侠长辉,王娅辉,刘伟敬^*,刘玉宁^*.刘玉宁教授运用活血化瘀法治疗肾脏病的经验[J].中国中西医结合肾病杂志,2020,21(07):568-570..............147

[78] 黄一珊,张帅星,刘伟敬^*,刘玉宁^*.黄芪在肾脏病中的应用及不良反应[J].中国中西医结合肾病杂志,2020,21(06):550-552..............................................148

[79] 张承承,韩雪婷,刘伟敬^*,刘玉宁^*.下瘀血汤调控AQP2表达改善SHR肾小管损伤实验研究[J].中国中西医结合肾病杂志,2020,21(05):384-387+471......149

[80] 张承承,宋越,蔡雨孜,刘伟敬^*,刘玉宁^*.清热方改善糖尿病肾病大鼠肾小管自噬应激的实验研究[J].中国中西医结合肾病杂志,2020,21(04):330-332+382.

...................................................................................................................................150

[81] 朱泽兵,侠晨辉,郭科婷,娄文娇,杨蕊冰,刘玉宁^*,刘伟敬^*.基于网络药理学探讨六味地黄丸治疗糖尿病肾病的作用机制[J].中国中西医结合肾病杂志,2020,21(04):340-343+381...............................................................................151

[82] 孙长胜,王玉芹,兰小燕,李春如,龙文君,王静春,陈桃宝,周宏灏^*,刘伟敬^*.复方蝉花片对2型糖尿病患者的临床疗效及安全性评价[J].药物评价研究,2020,43(04):655-659.......................................................................................152

[83] 王格,朱泽兵,孙卫卫,董贺,陈宇,刘玉宁,王耀献^*,刘伟敬^*.Ⅳ型心肾综合征中医证候分布及相关因素分析[J].中国中西医结合肾病杂志,2020,21(03):202-206............................................................................................................................153

[84] 崔海兰,宋越,黄一珊,孙莉娜,冯贺妍,李春,陈晓风,符馨文,戴润,张帅星,刘伟敬^*,刘玉宁^*.疏利分消法治疗特发性膜性肾病的临床观察[J].中国中西医结合肾病杂志,2020,21(03):218-220......................................................................154

[85] 张守琳,谢院生,魏连波,余仁欢,张宁,李侠,方敬爱^*,刘伟敬^*,刘玉宁^*.肾性血尿的诊断及中医治疗思路与方法[J].中国中西医结合肾病杂志,2020,21(03):270-272......................................................................................155

[86] 姜韩雪,刘玉宁,侠晨辉,朱泽兵,章友康,刘宝利,刘伟敬^*.特发性膜性肾病诊治进展[J].中国临床医生杂志,2020,48(02):145-148..................................156

[87] 刘玉宁,方敬爱,刘伟敬.肾脏病的中医六经辨证思路与方法[J].中国中西医结合肾病杂志,2020,21(01):1-4......................................................................157

[88] 许宗颖,张冬梅,陆瑞敏,张迪,舒展,陈萌^*.基于网络药理学探讨乌梅丸治疗糖尿病肠病的作用机制[J/OL].海南医学院学报:1-16[2020-12-31].https://doi.org/10.13210/j.cnki.jhmu.20200606.001........................158[89] 李克嵩,巩勋,姜泉^*,王建,刘蔚翔,李延婷,翟争,刘岩.863例女性类风湿关节炎患者不同证候与相关指标关系探讨[J].中国中医骨伤科杂志,2020,28(10):10-12+16....................................................................................159

[90] 李平,谢院生,童安荣,郭兆安,周静威,方敬爱^*,刘伟敬^*,刘玉宁^*.肾脏病蛋白尿的中西医结合诊断及治疗[J].中国中西医结合肾病杂志,2020,21(05):468-470............................................................................................................................160